Clinical Trial Update: Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and tolerability of human neural stem cells for Huntington's disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Human neural stem cells (neural stem cells)

Snippet

Sponsor: Leslie Thompson | Conditions: Huntington Disease | Phase 1, Phase 2 | Status: RECRUITING